EB1B-202: The beneficiary was a well-established scientist with strong expertise in biostatistics. She was working at a private research hospital in the United States. The beneficiary earned an M.S. in Statistical Practice at Boston University in the United States. She co-authored and published 11 journal research articles. These publications were cited about 145 times. The petition was filed in 2025 and approved one week later (No RFE; TSC; premium processing).
EB1B-201: The beneficiary was an internationally recognized outstanding scientist with strong expertise in plant molecular biology, working at a private university in the United States. The beneficiary earned a Ph.D. in Molecular Biology at Tata Institute of Fundamental Research, Mumbai, India. He published six journal research articles. These publications were cited about 142 times. The petition was filed in 2025 and approved two weeks later (No RFE; NSC; premium processing).
EB1B-200: The beneficiary was a well-established scientist with strong expertise in biochemistry, molecular biology, and cell biology, working at a research hospital in the United States. The beneficiary earned both an M.S. in Biochemistry and Molecular Biology and a Ph.D. in Integrative Sciences and Engineering from the National University of Singapore. She published eight journal research articles. These publications were cited about 200 times. The petition was filed in 2025 and approved 11 days later (No RFE; TSC; premium processing).
EB1B-199: The beneficiary was a well-established scientist with broad expertise and knowledge in biochemistry, molecular biology, microbiology, metabolism, and oncology, working at a research hospital in the United States. The beneficiary earned a Ph.D. in Experimental and Clinical Pharmacology at the University of Minnesota. He published 16 journal research articles. These publications were cited about 166 times. The petition was filed in 2025 and approved 10 days later (No RFE; TSC; premium processing).
EB1B-198: The beneficiary was a well-established scientist with strong expertise in plant molecular biology, working at a private research institute in the United States. The beneficiary earned a Ph.D. in Plant Biotechnology in Italy. He published 21 journal research articles. These publications were cited about 660 times. The petition was filed in 2023 and approved 17 months later (No RFE; NSC; requested for premium processing after pending for 16 months).
EB1B-197: The beneficiary was a well-established scientist with strong expertise in organic chemistry, working at a small chemical company in the United States. The beneficiary earned a Ph.D. in Organic Chemistry at the University of Pittsburg in the United States. He published four journal research articles. These publications were cited about 400 times. The petition was filed in 2024 and approved 50 days later (No RFE; NSC; premium processing).
EB1B-196: The beneficiary was a well-established scientist with strong expertise in environmental engineering, microbiology, and animal science., working at a private university in the United States. The beneficiary earned an M.S. in Environmental Engineering at the University of Missouri-Columbia and a Ph.D. in Environmental Engineering at The University of Tennessee. She published 10 journal research articles. These publications were cited about 140 times. The petition was filed in 2024 and approved 18 days later (No RFE; NSC; premium processing).
EB1B-195: The beneficiary was a plant scientist (plant and agricultural sciences, plant pathology), working at a private research institute in the United States. The beneficiary received his Ph.D. in Pharmaceutical Biology in Germany. He published 10 journal research articles. These publications were cited about 149 times. The petition was filed in 2023 and approved 14 months later (No RFE; NSC; premium processing was request after pending 14 months).
EB1B-194: The beneficiary was a chemical scientist (chemistry and chemical engineering), working at a start-up company in the United States. The beneficiary received her Ph.D. in Organic Chemistry in the United States. She published seven journal research articles. These publications were cited about 300 times. The petition was filed in 2024 and approved one week later (No RFE; TSC; premium processing).
EB1B-193: The beneficiary was a tenure-track assistant professor (computer science), working at a public university in the United States. The beneficiary received her Ph.D. in Computer Science in the United States. She published 13 journal and conference research articles. These publications were cited about 182 times. The petition was filed in 2024 and approved two weeks later (No RFE; NSC; premium processing).
EB1B-192: The beneficiary was a chemical scientist (organic chemistry, organic synthesis). He worked at a chemical company in the United States. The beneficiary received graduate education in the United States. He published nine journal research articles. These publications were cited about 214 times. The petition was filed in 2024 and approved nine days later (No RFE; TSC; premium processing).
EB1B-191: The beneficiary was a plant scientist (marine plants, sea grasses). She worked at a private research institute in the United States. The beneficiary earned her Ph.D. degree in China. She published 14 journal research articles. These publications were cited about 530 times. The petition was filed in 2024 and approved five days later (No RFE; NSC; premium processing).
EB1B-190: The beneficiary was a biomedical scientist (molecular biology, immunology). She worked at a medical school in the United States. The beneficiary earned her Ph.D. degree in Japan. She published 15 journal research articles. These publications were cited about 1,100 times. The petition was filed in 2023 and approved 12 months later (After RFE; TSC).
EB1B-189: The beneficiary was an information scientist (computer science and information technology, biomedical engineering). He worked at a medical school in the United States. The beneficiary earned his Ph.D. degree in China. He published 13 journal research articles. These publications were cited about 175 times. The petition was filed in 2024 and approved one month later (After RFE; NSC; premium processing).
EB1B-188: The beneficiary was a plant scientist (plant molecular biology). She worked at a private research institute in the United States. The beneficiary earned her Ph.D. degree in the United States. She published eight journal research articles. These publications were cited about 254 times. The petition was filed in 2023 and approved eight days later (No RFE; NSC; premium processing).
EB1B-187: The beneficiary was a chemical scientist (chemistry, materials science, biotechnology). He worked at a small biotechnology company in the United States. The beneficiary earned his Ph.D. degree in the United States. He published eight journal research articles. These publications were cited about 198 times. The petition was filed in 2023 and approved nine days later (No RFE; NSC; premium processing).
EB1B-186: The beneficiary was a biomedical scientist (cancer research). He worked at a cancer research hospital in the United States. The beneficiary earned his Ph.D. degree in India. He published 14 journal research articles. These publications were cited about 217 times. The petition was filed in 2023 and approved six weeks later (After RFE; TSC; premium processing).
EB1B-185: The beneficiary was a biomedical scientist (biochemistry, molecular biology and immunology). She worked at a start-up biotechnology company in the United States. The beneficiary earned her Ph.D. degree in Argentina. She published eight journal research articles. These publications were cited about 71 times. The petition was filed in 2023 and approved 9 days later (No RFE; NSC; premium processing).
EB1B-184: The beneficiary was a medical scientist (nuclear medicine, cancer research, biophysics, computational biology). He worked at a private research institution in the United States. The beneficiary earned his medical and graduate education in China. He published five English journal research articles. These publications were cited about 223 times. The petition was filed in 2023 and approved 9 days later (No RFE; NSC; premium processing).
EB1B-183: The beneficiary was a chemical scientist (chemistry, organic synthesis, drug development). He worked at a small chemical company in the United States. The beneficiary earned his M.S. in China and Ph.D. in the United States. He published 15 journal research articles. These publications were cited about 342 times. The petition was filed in 2023 and approved 10 days later (No RFE; TSC; premium processing).
EB1B-182: The beneficiary was a chemical scientist (organic synthesis, drug development). He worked at a small chemical company in the United States. The beneficiary earned his M.S. in China and Ph.D. in the United States. He published seven journal research articles. These publications were cited about 71 times. The petition was filed in 2022 and approved six months later (No RFE; TSC; premium processing).
EB1B-181: The beneficiary was a chemical and environmental scientist (analytical chemistry, environmental science). She worked at a small biotechnology company in the United States. The beneficiary earned her M.S. in China and Ph.D. in the United States. She published 10 journal research articles. These publications were cited about 246 times. The petition was filed in 2023 and approved ten days later (No RFE; NSC; premium processing).
EB1B-180: The beneficiary was a medical scientist (biostatistics, cancer research, clinical data analysis). She worked at a cancer research hospital in the United States. The beneficiary earned her M.E. in China and M.S. in the United States. She published 23 journal research articles. These publications were cited about 480 times. The petition was filed in 2023 and approved two months later (After Notice of Intent to Deny; TSC; premium processing).
EB1B-179: The beneficiary was a chemical scientist (analytical chemistry, proteomics, cancer research). He worked at a cancer research hospital in the United States. The beneficiary earned his M.S. in China and Ph.D. in the United States. He published 34 journal research articles. These publications were cited about 750 times. The petition was filed in 2023 and approved ten days later (No RFE; TSC; premium processing).
EB1B-178: The beneficiary was a biomedical scientist (biochemistry, molecular biology, cell biology, cancer research). She worked at a cancer research hospital in the United States. The beneficiary earned her M.S. and Ph.D. degrees in Canada. She published six journal research articles. These publications were cited about 260 times. The petition was filed in 2023 and approved one month later (After RFE; TSC; premium processing).
EB1B-177: The beneficiary was a biomedical scientist (biochemistry, molecular biology, cell biology, neuroscience). He worked at a private university in the United States. The beneficiary earned his Ph.D. in the United States and published nine journal research articles. These publications were cited about 271 times. The petition was filed in 2023 and approved six days later (No RFE; NSC; premium processing).
EB1B-176: The beneficiary was a chemical scientist (organic synthesis, biosensors, assay development) working at a small chemical synthesis company. He earned his Ph.D. in Chemistry in the United States and published 10 journal research articles. These publications were cited about 190 times. The petition was filed in 2023 and approved one week later (No RFE; TSC; premium processing).
EB1B-175: The beneficiary was a biomedical scientist (immunology, toxicology, cancer research). She worked at a small pharmaceutical company in the United States. The beneficiary received her Ph.D. in the United States and published ten journal research articles. These publications were cited about 218 times. The petition was filed in 2022 and approved one month later (After RFE; NSC; premium processing).
EB1B-174: The beneficiary was a biomedical scientist (proteomics, pancreatic cancer, cancer drug development). He worked at a private research hospital in the United States. The beneficiary received his Ph.D. in the United Kingdom and published six journal research articles. These publications were cited about 300 times. The petition was filed in 2022 and approved six days later (No RFE; TSC; premium processing).
EB1B-173: The beneficiary was a biomedical scientist (microbiology, medicinal chemistry, cancer drug development). She worked at a private research hospital in the United States. The beneficiary received her Ph.D. in China and published 18 journal research articles. These publications were cited about 177 times. The petition was filed in 2022 and approved 4 days later (No RFE; TSC; premium processing).
EB1B-172: The beneficiary was a biomedical scientist (biochemistry, proteomics, systems biology). He worked at a private research institute in the United States. The beneficiary received his Ph.D. in India and published 17 journal research articles. These publications were cited about 241 times. The petition was filed in 2022 and approved three months later (after a notice of intent to deny; NSC; premium processing).
EB1B-171: The beneficiary was a biomedical scientist (biochemistry, molecular biology, cancer research, radiology). She worked at a private research hospital in the United States. The beneficiary received her M.D. and Ph.D. in China and published 10 journal research articles. These publications were cited about 532 times. The petition was filed in 2022 and approved 10 days later (No RFE; TSC; premium processing).
EB1B-170: The beneficiary was a biological and biomedical scientist (microbiology, animal and plant pathogens, pancreatic cancer). She worked at a famous private research hospital in the United States. The beneficiary received her Ph.D. in China and published five journal research articles. These publications were cited about 134 times. The petition was filed in 2022 and approved eight days later (No RFE; TSC; premium processing).
EB1B-169: The beneficiary was a biomedical scientist (brain tumors). He worked at a famous private research hospital in the United States. The beneficiary received his Ph.D. in Brazil and published 15 journal research articles. These publications were cited about 110 times. The petition was filed in 2022 and approved nine days later (No RFE; TSC; premium processing).
EB1B-168: The beneficiary was a biomedical scientist (cell metabolism, cancer metabolism, protein posttranslational modification, anti-tumor immunity). He worked at a famous private research hospital in the United States. The beneficiary received his Ph.D. in China and published eight journal research articles. These publications were cited about 480 times. The petition was filed in 2022 and approved six days later (No RFE; TSC; premium processing).
EB1B-167: The beneficiary was a scientist of materials and mechanical engineering (mechanobiology, cell migration, tissue morphogenesis ) working at a US medical school. He received his Ph.D. in the United States and published 18 journal research articles. These publications were cited about 590 times. The petition was filed in 2022 and approved four days later (No RFE; NSC; premium processing).
EB1B-166: The beneficiary was a medical scientist (cancer research, cell biology, breast cancer) working at a US research hospital. She received her Ph.D. in Hungary and published 11 journal research articles. These publications were cited about 200 times. The petition was filed in 2022 and approved ten days later (No RFE; TSC; premium processing).
EB1B-165: The beneficiary was a chemical scientist (analytical chemistry, biochemistry, proteomics, plant research) working at a US agricultural research institute. He received his Ph.D. in the United States and published 18 journal research articles. These publications were cited 930 times. The petition was filed in 2022 and approved eight days later (No RFE; NSC; premium processing).
EB1B-164: The beneficiary was a chemical scientist (organic synthesis, biosensors, assay development) working at a small chemical synthesis company. He received his Ph.D. in the United States and published 10 journal research articles. These publications were cited about 100 times. The petition was filed in 2021 and approved four months later (No RFE; TSC).
EB1B-163: The beneficiary was a plant scientist (plant genomics, plant RNAs, bioinformatics) working at a US agricultural research institute. He received his Ph.D. in the United States and published 11 journal research articles. These publications were cited 830 times. The petition was filed in 2022 and approved five days later (No RFE; NSC; premium processing).
EB1B-162: The beneficiary was a biomedical scientist (cancer research and therapy) working at a US medical school. He received his Ph.D. in China and published 11 journal research articles. These publications were cited about 520 times. The petition was filed in 2021 and approved two weeks later (No RFE; TSC; premium processing).
EB1B-161: The beneficiary was a biochemical scientist (biochemistry, biotechnology, protein science) working at a small biotechnology company. He received his Ph.D. in Canada and published eight journal research articles. These publications were cited 216 times. The petition was filed in 2021 and approved two weeks later (No RFE; TSC; premium processing).
EB1B-160: The beneficiary was a medical analysist (bioinformatics, cancer research) working at a US cancer research hospital. She received her M.S. in the United States and published 15 journal research articles. These publications were cited 276 times. The petition was filed in 2021 and approved one week later (No RFE; NSC; premium processing).
EB1B-159: The beneficiary was a medical scientist (multiple myeloma, drug discovery, proteasome inhibitors) working at a US cancer research hospital. She received her Ph.D. in China and published 15 journal research articles. These publications were cited 204 times. The petition was filed in 2021 and approved one week later (No RFE; NSC; premium processing).
EB1B-158: The beneficiary was a biomedical scientist (cancer therapies) working at a US research hospital. He received his Ph.D. in China and published nine journal research articles. These publications were cited about 79 times. The petition was filed in 2021 and approved two weeks later (No RFE; TSC; premium processing).
EB1B-157: The beneficiary was a tenure-track assistant professor (financial management, retirement plan) working at a US public university. He received his Ph.D. in the United States and published seven journal research articles. These publications were cited 31 times. The petition was filed in 2021 and approved two weeks later (No RFE; TSC; premium processing).
EB1B-156: The beneficiary was a chemical scientist (materials science, inorganic synthesis, drug development) working at a small pharmaceutical company. He received his Ph.D. in the United States and published 11 journal research articles. These publications were cited 107 times. The petition was filed in 2021 and approved one week later (No RFE; NSC; premium processing).
EB1B-155: The beneficiary was a plant scientist (plant genomics) working at a US agricultural research institute. He received his Ph.D. in the United States and published seven journal research articles. These publications were cited 203 times. The petition was filed in 2021 and approved one week later (No RFE; NSC; premium processing).
EB1B-154: The beneficiary was a plant scientist (small RNA biology) and worked at a US research institute. She received her Ph.D. in China and published ten journal research articles. These publications were cited over 690 times. The petition was filed in 2021 and approved one week later (No RFE; NSC; premium processing).
EB1B-153: The beneficiary was a medical scientist (bioinformatics, cancer immunotherapy) and worked at a US research hospital. She received her Ph.D. in China and published eight journal research articles. These publications were cited over 350 times. The petition was filed in 2021 and approved one week later (No RFE; TSC; premium processing).
EB1B-152: The beneficiary was a research assistant professor (biomedical engineering) and worked at a US medical school. She received her Ph.D. in China and published sixteen journal research articles. These publications were cited over 220 times. The petition was filed in 2020 and approved five months later (No RFE; TSC; premium processing).
EB1B-151: The beneficiary was a medical scientist (immunology, cell biology, biotechnology) and worked at a start-up biotechnology company. She received her Ph.D. in the United States and published eight journal research articles. These publications were moderately cited by others. The petition was filed in 2020 and approved two days later (No RFE).
EB1B-150: The beneficiary was a chemical scientist (proteomics) and worked at a US private research institute. He received his Ph.D. in India and published 25 journal research articles. These publications were widely cited by others. The petition was filed in 2020 and approved one week later (No RFE).
EB1B-149: The beneficiary was a chemical scientist (chemical synthesis) and worked at a small US chemical company. He received his Ph.D. in the United States and published fourteen journal research articles. These publications were moderately cited by others. The petition was filed in 2020 and approved three months later (After RFE).
EB1B-148: The beneficiary was a biological scientist (microbiology, plant disease) and worked at a US private research institute. She received her Ph.D. in China and published four journal research articles. These publications were modestly cited by others. The petition was filed in 2019 and approved one week later (No RFE).
EB1B-147: The beneficiary was a biomedical scientist (bioinformatics, drug research) and worked at a US research hospital. He received his Ph.D. in the United States and published five journal research articles. These publications were moderately cited by others. The petition was filed in 2020 and approved two weeks later (No RFE).
EB1B-146: The beneficiary was a medical scientist (cancer research) and worked as a postdoctoral research fellow at a US medical school. He received his Ph.D. in China and published 24 journal research articles. These publications were widely cited by others. The petition was filed in 2019 and approved two weeks later (No RFE).
EB1B-145: The beneficiary was a mechanical engineer and scientist (biomedical engineering, microfluidic technology, droplets, etc.) and worked at a US public university. But the beneficiary was sponsored by a future employer (a company). He received his Ph.D. in Canada and published nine journal research articles. These publications were modestly cited by others. The petition was filed in 2019 and approved two weeks later (No RFE).
EB1B-144: The beneficiary was a pharmacological scientist (natural products, pain research) and worked as a tenure-track Assistant Professor at a US pharmacy school. He received his Ph.D. in the United States and published 12 journal research articles. These publications were moderately cited by others. The petition was filed in 2019 and approved two weeks later (No RFE).
EB1B-143: The beneficiary was a biomedical scientist (cancer research) and worked at a US research hospital. He received his Ph.D. in The Netherlands and published about 7 journal research articles. These publications were widely cited by others. The petition was filed in 2019 and approved two weeks later (No RFE).
EB1B-142: The beneficiary was a plant scientist (plant genomics, genetics, and molecular biology) and worked at a US private research institute. He received his Ph.D. in South Korea and published 9 journal research articles. These publications were modestly cited by others. The petition was filed in 2019 and approved two weeks later (No RFE).
EB1B-141: The beneficiary was a biomedical engineering scientist (biotechnology development) and worked at a small US biotechnology company. He received his Ph.D. in the United States and published about 30 journal research articles. These publications were widely cited by others. The petition was filed in 2019 and approved two weeks later (No RFE).
EB1B-140: The beneficiary was a biomedical scientist (cancer research, pharmacology) and worked at a US private research hospital. She received her Ph.D. in China and published eleven journal research articles. These publications were moderately cited by others. The petition was filed in 2019 and approved two weeks later (No RFE).
EB1B-139: The beneficiary was a neuroscientist (brain imaging and data analysis) and worked at a small US biotechnology company. She received her Ph.D. in the United States and published three journal research articles. These publications were moderately cited by others. The petition was filed in 2019 and approved two weeks later (No RFE).
EB1B-138: The beneficiary was a biomedical scientist (cancer research, immunotherapy) and worked at a US private research hospital. He received his Ph.D. in Canada and published nine journal research articles. These publications were moderately cited by others. The petition was filed in 2019 and approved two weeks later (No RFE).
EB1B-137: The beneficiary was a chemical scientist (medicinal chemistry, drug development) and worked at a US private research hospital. He received his Ph.D. in China and published twelve journal research articles. These publications were modestly cited by others. The petition was filed in 2019 and approved two weeks later (No RFE).
EB1B-136: The beneficiary was a biomedical scientist (bioinformatics, computational biology) and worked at a US private research hospital. He received his Ph.D. in China and published fifteen journal and conference research articles. These publications were modestly cited by others. The petition was filed in 2019 and approved two weeks later (No RFE).
EB1B-135: The beneficiary was a biological scientist (structural biology, HIV) and worked at a US private research hospital. He received his Ph.D. in China and published six journal research articles. These publications were modestly cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).
EB1B-134: The beneficiary was a biomedical scientist and engineer (biomedical engineering, biotechnology) and worked at a small US company. He received a Ph.D. in the United States and published over 20 journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).
EB1B-133: The beneficiary was a chemical scientist (synthesis of anti-cancer drugs) and worked at a US private research hospital. He received a Ph.D. in China and published about ten journal research articles. These publications were modestly cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).
EB1B-132: The beneficiary was a biomedical scientist (cancer research) and worked at a US private research hospital. He received a Ph.D. in China and published six journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).
EB1B-131: The beneficiary was a biomedical scientist (cancer research) and worked at a US private research hospital. He received a Ph.D. in China and published eight journal research articles. These publications were widely cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).
EB1B-130: The beneficiary was a scientist (plant science) and worked at a US private research institute. He received a Ph.D. in the United States and published several research articles. These publications were modestly cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).
EB1B-129: The beneficiary was a scientist (bioinformatics, computational biology, cancer research) and worked at a US research hospital. He received a Ph.D. in China and published seven research articles, two reviews, and one book chapter. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).
EB1B-128: The beneficiary was a medical scientist (cancer research) and worked at a US research hospital. He received a Ph.D. in the United States and published a few journal research articles. These publications were modestly cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).
EB1B-127: The beneficiary was a medical scientist (bioinformatics, cancer research) and worked at a US research hospital. He received a Ph.D. in China and published about ten journal research articles. These publications were moderately cited by others. The petition was filed in 2018 and approved two weeks later (No RFE).
EB1B-126: The beneficiary was a medical scientist (genetics, cancer research) and worked at a US research hospital. She received a Ph.D. in China and published a few journal research articles. These publications were modestly cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).
EB1B-125: The beneficiary was a biochemical scientist (structural biology, cell division) and worked at a small US biotechnology company. He received a Ph.D. in the United States and published a few journal research articles. These publications were modestly cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).
EB1B-124: The beneficiary was a plant scientist (genomics, breeding) and worked at a US private research institute. She received a Ph.D. in the United States and published over several journal research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).
EB1B-123: The beneficiary was a biochemical scientist (neuroscience, plant science) and worked at a US private research institute. He received a Ph.D. in the United States and published a few journal research articles. These publications were modestly cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).
EB1B-122: The beneficiary was a medical scientist (cancer research) and worked at a US research hospital. She received a Ph.D. in China and published over ten journal research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved six months later (No RFE).
EB1B-121: The beneficiary was a biomedical scientist (RNA biology and biotechnology, drug delivery) and worked at a small US biotechnology company. She received a Ph.D. in the United States and published over ten journal research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).
EB1B-120: The beneficiary was a research scientist (immunology, microbiology, vaccine) and worked at a US medical school. She received a Ph.D. in China and published over ten journal research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved several months later (No RFE).
EB1B-119: The beneficiary was a tenured Associate Professor (petroleum engineering) and worked at a US public university. He received a Ph.D. in the United States and published about ten journal and conference research articles. These publications were modestly cited by others. The petition was filed in 2017 and approved several days later (No RFE).
EB1B-118: The beneficiary was a biomedical scientist (cancer research) and was a research scientist at a U.S. cancer research and treatment hospital. She received a Ph.D. in the United States and published several research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved several days later (No RFE).
EB1B-117: The beneficiary was a chemist and biomaterials scientist (water treatment, biomass, etc.) and was a research scientist at a U.S. private company. He received a Ph.D. in the United States and published several research articles. These publications were modestly cited by others. The petition was filed in 2017 and approved one month later (after RFE).
EB1B-116: The beneficiary was a plant scientist (plant proteomics) and was a research scientist at a U.S. private research institute. He received a Ph.D. in the United States and published several research articles. These publications were modestly cited by others. The petition was filed in 2017 and approved several days later (No RFE).
EB1B-115: The beneficiary was a biochemical scientist (cancer research) and was a research scientist at a U.S. medical school. She received a Ph.D. in Canada and published over ten research articles. Some publications were widely cited by others. The petition was filed in 2017 and approved in 2017 (No RFE).
EB1B-114: The beneficiary was a biomedical scientist (immunology) and was a research scientist at a U.S. cancer research and treatment hospital. He received a Ph.D. in China and published several research articles. These publications were modestly cited by others. The petition was filed in 2017 and approved several days later (No RFE).
EB1B-113: The beneficiary was a biomedical scientist (cancer research) and was a research scientist at a U.S. medical school. He received a Ph.D. in China and published over ten research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved in 2017 (No RFE).
EB1B-112: The beneficiary was a biomedical scientist (immunology) and was a research scientist at a U.S. medical school. She received a Ph.D. in China and published over ten research articles. These publications were moderately cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).
EB1B-111: The beneficiary was a crop and plant scientist (crop breeding) and was a research scientist at a U.S. biotechnology company. She received a Ph.D. in Canada and published ten research articles, one review, and one book chapter. Some publications were widely cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).
EB1B-110: The beneficiary was a social scientist (business analysis and administration) and was an Assistant Professor at a U.S. community college. She received a Ph.D. in India and co-authored/authored three books. These were almost no citations by others. The petition was filed in 2017 and approved two weeks later (No RFE).
EB1B-109: The beneficiary was a mathematical scientist (applied mathematics) and was an Assistant Professor at U.S. public university. He received a Ph.D. in the United States and published about ten journal research articles. These publications were modestly cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).
EB1B-108: The beneficiary was a chemical and biochemical scientist (RNA technology) and worked as at a small U.S.company. He received a Ph.D. in the United States and published about several journal research articles. These publications were minimally cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).
EB1B-107: The beneficiary was a biomedical scientist (immunology, cancer research) and worked as at a U.S. private research hospital. He received a Ph.D. in China and published about several journal research articles. These publications were modestly cited by others. The petition was filed in 2017 and approved two weeks later (No RFE).
EB1B-106: The beneficiary was a biological scientist (applied microbiology) and worked as at a U.S. public university. He received a Ph.D. in China and published about twenty journal research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).
EB1B-105: The beneficiary was a computer scientist (transportation technology/software) and worked as at a U.S. public university. He received a Ph.D. in the United States and published several journal and conference research articles. These publications were minimally cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).
EB1B-104: The beneficiary was a biomedical scientist (bioinformatics) and worked as at a U.S. start-up company. He received a Ph.D. in the United States and published several journal research articles. These publications were modestly cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).
EB1B-103: The beneficiary was a biomedical scientist (bioinformatics) and worked as at a U.S. start-up company. He received a Ph.D. in the United States and published several journal research articles. These publications were modestly cited by others. The petition was filed in 2016 and approved several days later (No RFE).
EB1B-102: The beneficiary was a biomedical scientist (bioinformatics) and worked as at a U.S. medical research institute. He received a Ph.D. in the United States and published several journal research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved two months later (After RFE).
EB1B-101: The beneficiary was a medical scientist (cancer research, cell biology, new treatments) and worked as at a U.S. medical research institute. She received a Ph.D. in the United States and published several journal research articles. Some publications were widely cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).
EB1B-100: The beneficiary was a marine scientist (ocean microbiology) and worked as at a U.S. Federal research agency. She received M.S. in China and Ph.D. in the United States and published some Chinese and English journal research articles. These publications were modestly cited by others. The petition was filed in 2016 and approved ten days later (No RFE).
EB1B-99: The beneficiary was a physical chemist (molecular structures) and worked as at a U.S. small company. He received Ph.D. in the United States and published several journal research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved one month later (After RFE).
EB1B-98: The beneficiary was a physicist (chip development) and worked at a U.S. start-up company. He received Ph.D. in Portugal and published about twenty journal research articles. These publications were moderately cited by others. The petition was filed in 2016 and approved several days later (No RFE).
EB1B-97: The beneficiary was a toxicologist (neurotoxicity) and worked at a U.S. public university. She received Ph.D. in the United States and published over ten journal research articles. These publications were moderately cited by others. The petition was filed in 2015 and approved in 2016 (No RFE).
EB1B-96: The beneficiary was a tenure-track Assistant Professor (mathematics) and worked at a U.S. public university. He received Ph.D. in Canada and published over ten journal research articles. These publications were modestly cited by others. The petition was filed in 2016 and approved one week later (No RFE).
EB1B-95: The beneficiary was a medical scientist (laboratory medicine) and was a research scientist at a U.S. public university. He received Ph.D. in China and published over ten journal research articles. These publications were modestly cited by others. The petition was filed in 2016 and approved one week later (No RFE).
EB1B-94: The beneficiary was a chemical and pharmacological scientist (chemical synthesis) and was a research scientist at a U.S. public university. She received Ph.D. in South Korea and published over ten journal research articles. These publications were modestly cited by others. The petition was filed in 2016 and approved one week later (No RFE).
EB1B-93: The beneficiary was a biomedical scientist (cancer; neurotoxicity) and was a research scientist at a U.S. public university. He received Ph.D. in the United States and published several journal research articles. These publications were modestly cited by others. The petition was filed in 2016 and approved one week later (No RFE).
EB1B-92: The beneficiary was a geological scientist (maritime geology) and was a tenure-track Assistant Professor at a U.S. public college. He received Ph.D. in the United States and published four journal research articles and eight technical reports. These publications were modestly cited by others. The petition was filed in 2016 and approved one week later (No RFE).
EB1B-91: The beneficiary was a medical scientist (brain injury therapies) and worked at a U.S.medical school. She received Ph.D. in India and published several journal research articles, which were minimally cited by others. The petition was filed in 2016 and approved two weeks later (No RFE).
EB1B-90: The beneficiary was a physicist (theoretical physics) and worked at a U.S. federal research agency. He was hired by a private company that qualified as an EB1B petitioner. The beneficiary received Ph.D. in the United States and published six journal research articles. These publications were modestly cited by others. The petition was filed in 2016 and approved several days later (No RFE).
EB1B-89: The beneficiary was a chemical scientists (medicinal chemistry) and worked at a U.S. public university. He was offered a position by a very small chemical company. The beneficiary received Ph.D. in China and published several research articles. These publications were minimally cited by others. The petition was filed in 2015 and approved in 2016 (No RFE).
EB1B-88: The beneficiary was an Associate Professor (reliability engineering) and worked at a U.S. public university. He received Ph.D. in the United States and published over 90 peer-review journal and conference research articles. These publications were moderately cited by others. The petition was filed in 2015 and approved several days later (No RFE).
EB1B-87: The beneficiary was an electrical and biomedical engineer (biotechnology) and worked at a U.S. small company. He received Ph.D. in the United States and published several research articles. These publications were modestly cited by others. The petition was filed in 2015 and approved several days later (No RFE).
EB1B-86: The beneficiary was an biomedical scientist (bioinfomcatics) and worked at a U.S. medical school. He received Ph.D. in the United States and published several research articles. These publications were minimally cited by others. The petition was filed in 2015 and approved several months later (No RFE).
EB1B-85: The beneficiary was an biological scientist (cell biology, biotechnology) and worked at a small start-up biotechnology company. He received Ph.D. in the United States and published about ten research articles. These publications were moderately cited by others. The petition was filed in 2015 and approved several days later (No RFE).
EB1B-84: The beneficiary was an computer scientist and engineer (computer science and technology) and worked as a tenure-track Assistant Professor at a US university. He received Ph.D. in the United States and published over ten journal and conference papers. These publications were modestly cited by others. The petition was filed in 2015 and approved several days later (No RFE).
EB1B-83: The beneficiary was an electrical engineer (power system) and worked at a small US company. She received Ph.D. in the United States and published over ten journal and conference papers. These publications were modestly cited by others. The petition was filed in 2015 and approved one week later (No RFE).
EB1B-82: The beneficiary was a bioinformatics scientist (RNA alternative splicing) and worked at a US biotechnology company. She received M.S. in the United States and published several research papers. These publications were widely cited by others. The petition was filed in 2015 and approved one week later (No RFE).
EB1B-81: The beneficiary was an atmospheric and environmental scientist (oceanography) and worked at a US Federal agency. He received Ph.D. in the United States and published several research papers. One paper was widely cited by others. The petition was filed in 2015 and approved one week later (No RFE).
EB1B-80: The beneficiary was a medical scientist (diabetes and cardiovascular disease) and worked at a US medical school. She received M.S. in Canada and published over ten research papers. These publications were moderately cited by others. The petition was filed in 2015 and approved one week later (No RFE).
EB1B-79: The beneficiary was a medical scientist (cancer research) and worked at a US medical school. She received Ph.D. in China and published several research papers. These publications were moderately cited by others. The petition was filed in 2015 and approved one week later (No RFE).
EB1B-78: The beneficiary was a biomedical scientist and worked at a US medical school. She received Ph.D. in the United Kingdom and published several research papers. One paper was widely cited by others. The petition was filed in 2015 and approved one week later (No RFE).
EB1B-77: The beneficiary was a molecular biologist and worked at a small biotechnology company. He received Ph.D. in the United States and published several research papers. Some papers were widely cited by others. The petition was filed in 2014 and approved two weeks later (No RFE).
EB1B-76: The beneficiary was a plant scientist and worked at a US private research institute. She received M.S. in the United States and published several research papers. Two papers were widely cited by others. The petition was filed in 2014 and approved one month later (after RFE).
EB1B-75: The beneficiary was a computer scientist and engineer and worked at a small company. He received PhD in the United States and published several research papers. Two papers were widely cited by others. The petition was filed in 2014 and approved several a few days later (No RFE).
EB1B-74: The beneficiary was a biochemical scientist (high throughput screening) and worked at a U.S. public university. She received PhD in the United States and published several research papers. These papers were moderately cited by others. The petition was filed in 2014 and approved several months later (No RFE).
EB1B-73: The beneficiary was a physical scientist (spectroscopic instruments) and worked at a small U.S. company. He received PhD in the United States and published several research papers. These papers were moderately cited by others. The petition was filed in 2014 and approved one week later (after RFE).
EB1B-72: The beneficiary was a biomedical scientist (breast cancer) and worked at a US medical. He received PhD in China and published several research papers. These papers were moderately cited by others. The petition was filed in 2014 and approved one week later (No RFE).
EB1B-71: The beneficiary was a biochemist (biomaterials) and worked at a US public university. He received PhD in the United States and published about ten research papers. These papers were minimally cited by others. The petition was filed in 2014 and approved two months later (After NOID).
EB1B-70: The beneficiary was a medical scientist (immunology) and worked at a US medical school. He received PhD in Germany and published over ten research papers. Some papers were widely cited by others. The petition was filed in 2014 and approved two months later (No RFE).
EB1B-69: The beneficiary was a chemical engineer (new battery technology) and worked at a small start-up company. He received PhD in China and published over ten research and review papers. Some papers were widely cited by others. The petition was filed in 2014 and approved several days later (No RFE).
EB1B-68: The beneficiary was a medical scientist (oxidative stress and blood research) and worked at a US public university. He received PhD in China and published about ten research papers. These papers were moderately cited by others. The petition was filed in 2014 and approved several days later (No RFE).
EB1B-67: The beneficiary was a food and grain scientist (rice research) and worked at a US public university. She received PhD in China and published about ten research papers. These papers were moderately cited by others. The petition was filed in 2014 and approved several days later (No RFE).
EB1B-66: The beneficiary was a biomedical scientist (bone disease) and worked at a US medical school. He received PhD in the United States and published several journal research papers. These papers were minimally cited by others. The petition was filed in 2013 and approved in 2014 (after NOID).
EB1B-65: The beneficiary was an electrical engineer (automatic target recognition and tracking) and worked at a very small research and development company. He received PhD in the United States and published several journal and conference papers. These papers were minimally cited by others. The petition was filed in 2013 and approved two months later (no RFE).
EB1B-64: The beneficiary was a physical scientist (physics) and worked as a tenure-track Assistant Professor at a U.S. university. He received PhD in the United States and published three journal research papers. These papers were minimally cited by others. The petition was filed in 2013 and approved several days later (no RFE).
EB1B-63: The beneficiary was a computer and electrical engineer and scientist (unmanned air and ground vehicles) and worked at a very small research and development company. He received PhD in the United States and published about fifteen journal and conference papers. These papers were minimally cited by others (~ 40). The petition was filed in 2013 and approved two months later (no RFE).
EB1B-62: The beneficiary was a chemical scientist (organic chemistry) and worked at a very small chemical research company (6 employees). He received PhD in the United States and published four research papers and filed one patent application. These papers were minimally cited by others (< 20). The petition was filed in 2013 and approved several days later (no RFE).
EB1B-61: The beneficiary was a chemical scientist (organic chemistry) and worked at a small pharmaceutical research company. He received PhD in the United States and published over ten research papers. These papers were moderately cited by others. The petition was filed in 2013 and approved several days later (no RFE).
EB1B-60: The beneficiary was a civil engineer (transportation programming) and worked at a small company. He received PhD in the United States and published three peer-reviewed journal papers. These papers were minimally cited by others. The petition was filed in 2013 and approved one and a half months later (no RFE).
EB1B-59: The beneficiary was a chemical scientist (nanomedicine, renewable energy) and worked at a very public university. He received PhD in the United States and published over ten peer-reviewed journal papers. These papers were moderately cited by others. The petition was filed in 2013 and approved several months later (no RFE).
EB1B-58: The beneficiary was a medical scientist (cardiovascular diseases) and worked at a very medical school. He received PhD in another country and published over ten peer-reviewed journal papers. These papers were moderately cited by others. The petition was filed in 2013 and approved several days later (no RFE).
EB1B-57: The beneficiary was a mechanical engineer and worked at a very small US company. He received PhD in the United States and published about ten journal and conference papers. These papers were minimally cited by others. The petition was filed in 2013 and approved several days later (no RFE).
EB1B-56: The beneficiary was a tenure-track Assistant Professor (computer engineering) working at a US public university. He received Ph.D. in the United States and published about 40 journal and conference papers. These publications were modestly cited by others. The petition was filed in 2013 and approved several days later.
EB1B-55: The beneficiary was a plant scientist (symbiotic fungi, nitrogen fixation) working at a US public university. He received Ph.D. in another country and published over ten journal papers. These publications were modestly cited by others. The petition was filed in 2013 and approved several days later.
EB1B-54: The beneficiary was a biological and biotechnology scientist (development/DNA sequencing) working at a small US company. He received Ph.D. in the United States and published several journal papers. These publications were modestly cited by others. The petition was filed in 2013 and approved several days later.
EB1B-53: The beneficiary was a medical scientist working at a small US company. She received M.S. in the United States and published six journal papers. These publications were modestly cited by others. The petition was filed in 2013 and approved one day later.
EB1B-52: The beneficiary was a bioinformatics scientist working at a US medical school. He received PhD in the United States and published more than ten journal papers. These publications were modestly cited by others. The petition was filed in 2013 and approved one day later.
EB1B-51: The beneficiary was a medical scientist working at a US medical school. He received PhD in another country and published more than ten journal papers. These publications were modestly cited by others. The petition was filed in 2013 and approved several days later.
EB1B-50: The beneficiary was a chemical and biochemical scientist working at a small US company with three full-time researchers. He received PhD in the United States and published more than ten journal papers. These publications were modestly cited by others. The petition was filed in 2013 and approved several weeks later.
EB1B-49: The beneficiary was a physical scientist (materials science) working at a small US company. He received PhD in the United States and published three journal papers and some conference papers. These publications were cited about 40 times. The petition was filed in 2012 and approved several days later.
EB1B-48: The beneficiary was a chemical scientist (analytical chemistry) working at a small US company. He received PhD in the United States and published a few papers in international journals. The petition was filed in 2012 and approved several days later.
EB1B-47: The beneficiary was a medical scientist (research on aging) at a small research institute. She received PhD in the United States and published several papers in international journals. The petition was filed in 2012 and approved several days later.
EB1B-46: The beneficiary was a medical scientist (prion disease and cancer research) at a US medical school. He received PhD in a foreign country and published about 20 papers in international journals. The petition was filed in 2012 and approved several days later.
EB1B-45: The beneficiary was a medical scientist (cardiovascular diseases and syndrome) at a US university medical school. He received PhD in a foreign country and published about 40 papers in international journals. The petition was filed in 2012 and approved two months later.
EB1B-44: The beneficiary was an Instructor (bone repair and regeneration) at a US university. She received PhD in a foreign country and published four papers in international journals. The petition was filed in 2012 and approved several days later. No RFE.
EB1B-43: The beneficiary was a tenure-track Assistant Professor (civil engineering) at a US company. He received PhD degree in the United States and published several journal and conference papers. The petition was filed in 2012 and approved two weeks later. No RFE.
EB1B-42: The beneficiary was a staff engineer (power systems) at a US company. He received PhD degree in the United States and published over ten journal and conference papers. The petition was filed in 2012 and approved one month later. No RFE.
EB1B-41: The beneficiary was a research scientist (biotechnology) at a US company. She received PhD degree in the United States and published four original research articles. The petition was filed in 2012 and approved three months later.
EB1B-40: The beneficiary was a research scientist (cardiovascular biology) at a US medical school. She received PhD degree in a foreign country. The petition was filed in 2012 and approved several days later with the request of premium processing service.
EB1B-39: The beneficiary was a research scientist (structural biology) at a US cancer research and treatment hospital. He received PhD degree in a foreign country. The petition was filed in 2012 and approved several days later with the request of premium processing service.
EB1B-38: The beneficiary was a research scientist at a US medical school. He received PhD degree in Pharmacology in a foreign country. The petition was filed in 2012 and approved several days later with the request of premium processing service.
EB1B-37: The beneficiary was a research scientist at a US medical school. He received a M.S degree in the United States and published three original research articles. The petition was filed in March 2012 and approved in April 2012, without the request of premium processing service.
EB1B-36: The beneficiary was a tenure-track Assistant Professor of Computer and Electronic Engineering at a US public university. He published numerous research articles and made significant original contributions. The petition was filed in 2012 and approved several days later.
EB1B-35: The beneficiary was a biomaterials scientist and worked as a research scientist at a US university. He also earned PhD in the United States. The petition was filed in 2012 and approved several days later.
EB1B-34: The beneficiary was an electrical engineer and worked at a world's leading high-tech comopany. He earned PhD in the Unites States. The petition was filed in 2012 and approved several days later.
EB1B-33: The beneficiary was a genomic scientist at a US public university. She earned PhD in a foreign country. When the petition was filed, the beneficiary published 9 research articles in international journals. The petition was filed in January, 2012, and approved several days later.
EB1B-32: The beneficiary was an electrical engineer at a small US company. He earned PhD in the United States and published over 10 research articles. The petition was filed in January, 2012, and approved several days later.
EB1B-31: The beneficiary was a bioinformatical scientist at a US research institute. He earned PhD in the United States and published several research articles. The petition was filed in January, 2012, and approved several days later.
EB1B-30: The beneficiary was a genetic scientist at a US public university. He earned PhD in a foreign country. When the petition was filed, the beneficiary published over 10 research articles. The beneficiary DID NOT provide review service for journals or conferences. The petition was filed in December, 2011, and approved in January, 2012.
EB1B-29: The beneficiary was a medical scientist at a US medical school. She earned PhD in a foreign country. When the petition was filed, the beneficiary published about 10 research articles which were modestly cited. The beneficiary DID NOT provide review service for journals or conferences. The petition was filed in August, 2011, and approved in December, 2011.
EB1B-28: The beneficiary was a medical scientist at a US research institute. He earned PhD degree in the United States. When the petition was filed, the beneficiary published several research articles which were independently cited for over 20 times. The beneficiary reviewed about 20 times for several international journals. The petition was filed in September, 2011, and approved in November, 2011.
EB1B-27: The beneficiary was a biostatistician and worked at a US medical school. She earned a M.S. degree in Statistics. When the petition was filed, the beneficiary published several co-authored research articles. One of the papers had significant influence in the international medical community. The petition was filed in February, 2011, and approved in October, 2011.
EB1B-26: The beneficiary was an Assistant Professor in Chemistry at a US private university. When the petition was filed, the beneficiary published about 15 research articles and these publications were cited about 100 times. The beneficiary frequently reviewed research manuscripts for international journals. The petition was filed in April, 2011, and approved in September, 2011.
EB1B-25: The beneficiary was a medical scientist at a US medical school. When the petition was filed, he published over 10 research articles. These publications were cited around 70 times. The beneficiary did NOT provide review services for journals or conferences. The petition was filed in March, 2011, and approved in September, 2011.
EB1B-24: The beneficiary was an electrical engineer at a small US high-tech company. When the petition was filed, the beneficiary published five journal articles and 10 conference papers. All the publications were cited by others around 30 times. The beneficiary was frequently invited to review research manuscripts for journals and conferences. The petition was filed in August, 2011, and approved several days later.
EB1B-23: The beneficiary was a research scientist at a small US company, specializing in cancer research. He published over 10 research articles; some of them were substantially cited. The beneficiary did not provide review services for journals or conferences. The petition was filed in July, 2011, and approved several days later.
EB1B-22: The beneficiary was a research engineer at a small US company, specializing in optical fiber communications. He published over 10 research articles; one of them was heavily cited by others. The beneficiary also provided review services for multiple journals. The petition was filed in June, 2011, and approved several days later.
EB1B-21: The beneficiary was a tenure-track Assistant Professor at a US university, specializing in bioorganic chemistry. He published over 10 research articles; some of them were substantially cited by others. The beneficiary did not provide review services. The petition was filed in July, 2011, and approved several days later.
EB1B-20: The beneficiary was an electrical and software engineer at a small high-tech company. When the petition was filed, the beneficiary published seven journal and conference papers, reviewed 17 times and accumulated a total of 40 citations to his work. The petition was filed in March, 2011, and approved in May, 2011.
EB1B-19: The beneficiary was an electrical and software engineer working at a high-tech startup company. When the petition was filed, the beneficiary published two journal articles and eight conference papers. All publications were cited by others less than 20 times. The beneficiary also reviewed a very large number of articles of others in the same or allied fields. The petition was filed in April, 2011 and approved several days later with the request of premium processing service.
EB1B-18: The beneficiary was a medical scientist working at a US leading cancer research and treatment institution. He obtained PhD in the United States and published two research articles from his graduate study. He also co-authored three journal articles as an undergraduate student in a foreign country. All these articles were cited by others for around 30 times. The beneficiary did NOT claim to have reviewed for journals or conferences. The petition was filed in September, 2010, and approved in April, 2011. No RFE.
EB1B-17: The beneficiary was a computer scientist and worked as a research assistant professor at a US university. He obtained PhD in the United States and published about 10 journal and conference papers. These papers were cited by others for less than 30 times. The beneficiary also provided review services for journals and conferences for many times. The petition was filed in February, 2011 and approved in March, 2011 with the request of premium processing. No RFE.
EB1B-16: The beneficiary was a cancer medical scientist. He earned PhD from a foreign university. When the case was filed, the beneficiary worked as a research associate at a US medical school. He published more than a dozen research articles which were collectively cited for about 60 times. The beneficiary also reviewed for three professional journals. The petition was filed in October, 2010 and approved in February, 2011. No RFE.
EB1B-15: The beneficiary was a mechanical engineer working for a small US company. When the petition was filed, the beneficiary published three English-language journal papers and two Chinese-language journal papers. These papers were modestly cited by others. The beneficiary also published several conference papers but none of them were cited. The beneficiary did NOT claim to have provided review services for journals or conferences. The petition was approved one month after filing.
EB1B-14: The beneficiary was a materials scientist at a US start-up company. She co-authored and published three English-language research papers and several Chinese-language papers. These publications were cited by others modestly. The beneficiary also served as a manuscript reviewer for five professional journals. The petition was approved 10 days after filing with the request of premium processing service. No RFE.
EB1B-13: The beneficiary was a chemical scientist at a very small US company. She published one original research article and one review article during her PhD graduate study in the United States. She also co-authored an original research article when studying in a foreign country. All the publications were modestly cited by others. The beneficiary did NOT provide any review services for journals or conferences. The petition was filed with the request of premium processing service. USCIS issued a request for further evidence (RFE) concerning the finacial ability of the small company (the petitioner) and subseqently approved the petition.
EB1B-12: The beneficiary was an Assistant Professor at a US university, specializing in second language teaching. She published one book chapter and several research articles. One article appeared in an international journal. All articles were cited by others for very few times. She also reviewed for two professional journals. The petition was approved 4 days after filing with the request of premium processing service. No RFE.
EB1B-11: The beneficiary was an Assistant Professor at a US university, specializing in computer science and networking. He published over 30 journal and conference articles, some of which were heavily cited by others. He also served as a judge and reviewed for over 30 times for different journals and conferences. The petition was approved 10 days after filing with the request of premium processing service. No RFE.
EB1B-10: The alien beneficiary was a senior research scientist at a top US private hospital. He made significant academic contributions during his graduate research and his research at the hospital. He published multiple research articles that were substantially cited by others. He did NOT provide any review services for journals or conferences. The petition was filed with the request for premium processing service and approved 10 days thereafter.
EB1B-9: The alien beneficiary was a physical scientist at a small US company. He made significant academic contributions during his graduate research at a US university. He published several research articles that were substantially cited by others. He also provided multiple review services for international journals. The petition was filed with the request for premium processing service and approved 6 days thereafter.
EB1B-8: The alien was an electrical engineer and worked at a major US company. He made significant academic contributions during his PhD graduate research. He also published many research articles in internationally circulatd journals and provided multiple review service for journals and international conferences. The petition was approved three months after filing. No RFE.
EB1B-7: the alien was a medical scientist and worked as a research associate at a US public university. He made academic contributions that attracted attention from international scholars. The alien also won two national awards in a foreign country and provided review service for several international journals. The petition was approved two months after filing. No RFE.
EB1B-6: The alien was a scholar of finance and tenure-track Assistant Professor at a U.S. public school. When the case was filed, the alien had three newly published journal articles and seven conference papers. Only one of the conference papers was cited by others for only one time. All other publications had no citations. However, one of the alien's publications was used by a professional training organization as teaching material. The petition was approved one week after filing. No RFE.
EB1B-5: The alien was a chemical scienitst and working in a very small company. When the petition was filed, the alien had published 10 journal research articles and was the co-inventor of four patent applications. All publications were cited by others for over 20 times. The alien did NOT provide review services for journals or conferences. The petition was approved three weeks after filing. No RFE.
EB1B-4: The alien was a medical scienits and working for a U.S. medical school. When the petition was filed, the alien had published 20 research articles. These articles were cited by others for about 90 times. The alien also decoded the sequences of six novel rat genes. The alien did not provide review services for journals or conferences. The petition was approved one week after filing. No RFE.
EB1B-3: The alien was an organic chemist and working for a U.S. medical school. When the petition was filed, the alien had published eight original research articles; these articles were cited by others for over 30 times. The alien also reviewed for over 30 times for professional journals. Part of the alien's work was highlighted in scientific news media. The petition was approved 35 days after the filing.
EB1B-2: The client was a biotechnologist and working at a U.S. university. The client earned Ph.D. in a foreign country and published eight research articles. These articles were cited for a total of 50 times. The client did not judge any work of others. Four weeks after filing, this petition was approved without RFE.
EB1B-1: The alien was a medical scientist and earned PhD in the United States. The alien was working for a small biotechnology company. When the petition was filed, the alien published thirteen research articles. These articles were cited for a total of 80 times. The alien also judged works of others for over 10 times. The petition was approved one week after filing. No RFE.